The clinical trial landscape is constantly changing. From new technology, trial designs and the US Food and Drug Administration (FDA) guidance on these developments to ebbs and flows in trial volume and advancements across therapeutic areas, it’s difficult to keep abreast of continuous shifts. However, staying on top of the ever-changing industry is essential for the success of clinical sites, no matter if one is an experienced site or looking to conduct research for the first time.
What are the current and upcoming trends in clinical research? How will they impact the site? What steps can be taken to optimize research practice and ensure that patients are provided with cutting-edge care in their community?
Join Elligo Health Research® for an exclusive webinar, “Setting Your Site up for Success Whether You Are New to Research or Experienced,” featuring industry experts Riley Kammer, Vice President, Network Expansion, Research Partnerships, Elligo Health Research, and Dawn Sauro, Chief Operating Officer, Elligo Health Research. This live webinar will include an overview of the rapidly evolving clinical trial landscape, the implications current and upcoming trends have for clinical sites and best practices to ensure success for both new and experienced research sites.
The speakers will explore ways to advance the development of new medicines and increase revenue while offering patients world-class treatments.
Riley Kammer, Vice President of Network Expansion, Elligo Health Research
Riley Kammer is the Vice President of Network Expansion at Elligo Health Research®. He focuses on expanding and diversifying Elligo’s robust network of research partner sites, practices and health systems. Prior to joining the team, Riley served as Director of Business Development at ClinEdge, leading sales strategy and execution for key business segments. As Director of Sponsor and CRO Alliances, he oversaw trial acquisition and placement by leading efforts to strengthen existing, and developed new, strategic partnerships with major pharma, biotech and contract research organizations. He started his career in finance, working in a variety of capacities at a healthcare-focused investment bank. Riley earned a bachelor’s degree in economics from Boston University.
Dawn Sauro, Chief Operating Officer, Elligo Health Research
Dawn Sauro has 30+ years of drug and device development experience, including working for sites, sponsors and CROs. She has experience across a broad spectrum of therapeutic areas, but her main area of expertise is in hematology and oncology. Having led several successful hematology/oncology development programs from First-in-Human through successful registration, she brings this expertise in delivery to help sponsors drive results.
Who Should Attend?
Attendees from the following industries:
- Clinical Research Sites
What You Will Learn
Attendees will gain insights into:
- An overview of the rapidly evolving clinical trial landscape
- The implications current and upcoming trends have for research sites
- Expert tips and best practices that are applicable to new and experienced sites
Elligo Health Research
Elligo Health Research accelerates clinical trials through healthcare with access to over 150 million known patients and their HIPAA-compliant healthcare data, our IntElligo® Research Stack technology, and our PatientSelect identification and engagement model. Coupled with the largest Known Patient Access Network, Elligo’s Site Solutions enable healthcare practices and research sites to participate in clinical trials. By adaptive engagement of known patients and physicians, we accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.